| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Hologic (NASDAQ:HOLX) reported quarterly earnings of $1.13 per share which beat the analyst consensus estimate of $1.10 by 2.73...
																	Wall Street opened the week on a mixed note on Monday.
																	
																	
																	
																	
																	
																	Mizuho analyst Anthony Petrone downgrades Hologic (NASDAQ:HOLX) from Outperform to Neutral and raises the price target from ...
																	Raymond James analyst Andrew Cooper downgrades Hologic (NASDAQ:HOLX) from Outperform to Market Perform.